Literature DB >> 9196421

Early implantation of multiple spring coils for severe haemolysis after incomplete transcatheter occlusion of persistent arterial duct.

Y F Cheung1, M P Leung, K T Chau.   

Abstract

An 18 month old girl with an angiographically measured ductus of 4.5 mm underwent transcatheter occlusion of the persistent arterial duct with a 17 mm Rashkind umbrella and an occluding spring coil. Severe intravascular haemolysis developed 20 hours later. Significant residual ductal leakage was noted and the residual duct measured 6 mm. Previous underestimation might have been related to ductal spasm as a catheter was placed across the duct before angiography. The haemolysis was abolished within 48 hours by a previously unreported approach of antegrade transcatheter closure of the residual duct by multiple spring coils.

Entities:  

Mesh:

Year:  1997        PMID: 9196421      PMCID: PMC484773          DOI: 10.1136/hrt.77.5.477

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  5 in total

1.  Severe haemolysis after transcatheter duct occlusion: a non-surgical remedy.

Authors:  A M Hayes; A N Redington; M L Rigby
Journal:  Br Heart J       Date:  1992-04

2.  Late transcatheter removal of a Rashkind PDA occlusion device for persistent hemolysis using a modified transseptal sheath.

Authors:  R G Grifka; M P O'Laughlin; C E Mullins
Journal:  Cathet Cardiovasc Diagn       Date:  1992-02

3.  Results of anterograde transcatheter closure of patent ductus arteriosus using single or multiple Gianturco coils.

Authors:  Z M Hijazi; R L Geggel
Journal:  Am J Cardiol       Date:  1994-11-01       Impact factor: 2.778

4.  Transcatheter occlusion of patent ductus arteriosus with Gianturco coils.

Authors:  T R Lloyd; R Fedderly; A M Mendelsohn; S K Sandhu; R H Beekman
Journal:  Circulation       Date:  1993-10       Impact factor: 29.690

5.  Nonsurgical closure of patent ductus arteriosus: clinical application of the Rashkind PDA Occluder System.

Authors:  W J Rashkind; C E Mullins; W E Hellenbrand; M A Tait
Journal:  Circulation       Date:  1987-03       Impact factor: 29.690

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.